首页|期刊导航|Medicine Plus|Transforming the landscape of cancer treatment with seven promising novel therapies:evolution and future perspectives

Transforming the landscape of cancer treatment with seven promising novel therapies:evolution and future perspectives

Huilei Miao Yuan Fang Chongxian Pan Hanshuo Yang Zhipeng Wang Ye Qi Yan Wu Ying Zhang Fangpeng Liu Huiyao Huang Yu Tang Dawei Wu Ning Li

Medicine Plus2025，Vol.2Issue(2)：P.46-69,24.

Medicine Plus2025，Vol.2Issue(2)：P.46-69,24.DOI:10.1016/j.medp.2025.100087

Transforming the landscape of cancer treatment with seven promising novel therapies:evolution and future perspectives

Huilei Miao ¹Yuan Fang ¹Chongxian Pan ²Hanshuo Yang ³Zhipeng Wang ⁴Ye Qi ⁵Yan Wu ⁶Ying Zhang ⁷Fangpeng Liu ⁸Huiyao Huang ¹Yu Tang ¹Dawei Wu ¹Ning Li¹

作者信息

1. Clinical Trials Center,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
2. Department of Medicine,Brigham and Women’s Hospital,Boston 02132,MA,USA
3. Department of Biotherapy,Cancer Center and State Key Laboratory of Biotherapy,West China Hospital,Sichuan University,Chengdu 610041,China
4. Likang Life Sciences Technology Co.,Ltd.,Beijing 100015,China
5. Neoevolution(Beijing)Medical Technology Co.,Ltd.,Beijing 102202,China
6. Abogen Biosciences,Suzhou Abogen Biosciences,Suzhou 215000,China
7. Nuwacell Biotechnologies Co.,Ltd.,Hefei 230088,China
8. Sugar Pharmaceutical Technology(Beijing)Co.,Ltd.,Beijing 102206,China
折叠

摘要

关键词

Cancer immunotherapy/Cell therapy/Gene therapy/MRNA therapeutics/Drug delivery systems

分类

医药卫生

引用本文复制引用

Huilei Miao,Yuan Fang,Chongxian Pan,Hanshuo Yang,Zhipeng Wang,Ye Qi,Yan Wu,Ying Zhang,Fangpeng Liu,Huiyao Huang,Yu Tang,Dawei Wu,Ning Li..Transforming the landscape of cancer treatment with seven promising novel therapies:evolution and future perspectives[J].Medicine Plus,2025,2(2):P.46-69,24.

基金项目

supported by the Chinese Academy of Medical Sciences Medical and Health Science and Technology Innovation Project(2023-I2M-C&T-B-094) （2023-I2M-C&T-B-094）

the Beijing Nova Program(20230484277) （20230484277）

the National Key Research and Development Program(2023YFC2508500). （2023YFC2508500）

Medicine Plus

ISSN：2097-289X

访问量0

下载量0

段落导航